Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $2.36 billion. The enterprise value is $3.51 billion.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 34.77 million shares outstanding. The number of shares has decreased by -1.13% in one year.
| Current Share Class | 34.77M |
| Shares Outstanding | 34.77M |
| Shares Change (YoY) | -1.13% |
| Shares Change (QoQ) | +0.89% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 104.60% |
| Float | 34.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.47 |
| PS Ratio | 2.00 |
| Forward PS | 2.04 |
| PB Ratio | 60.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.59 |
| P/OCF Ratio | 7.76 |
| PEG Ratio | 0.84 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.73, with an EV/FCF ratio of 14.27.
| EV / Earnings | n/a |
| EV / Sales | 2.98 |
| EV / EBITDA | 9.73 |
| EV / EBIT | 13.10 |
| EV / FCF | 14.27 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 32.00.
| Current Ratio | 1.42 |
| Quick Ratio | 0.62 |
| Debt / Equity | 32.00 |
| Debt / EBITDA | 3.32 |
| Debt / FCF | 5.06 |
| Interest Coverage | 3.61 |
Financial Efficiency
Return on equity (ROE) is -114.08% and return on invested capital (ROIC) is 22.48%.
| Return on Equity (ROE) | -114.08% |
| Return on Assets (ROA) | 9.03% |
| Return on Invested Capital (ROIC) | 22.48% |
| Return on Capital Employed (ROCE) | 21.58% |
| Weighted Average Cost of Capital (WACC) | 8.87% |
| Revenue Per Employee | $785,133 |
| Profits Per Employee | -$85,200 |
| Employee Count | 1,500 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 3.17 |
Taxes
In the past 12 months, Ingevity has paid $6.50 million in taxes.
| Income Tax | 6.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.20% in the last 52 weeks. The beta is 1.24, so Ingevity's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +59.20% |
| 50-Day Moving Average | 71.87 |
| 200-Day Moving Average | 62.75 |
| Relative Strength Index (RSI) | 42.50 |
| Average Volume (20 Days) | 246,633 |
Short Selling Information
The latest short interest is 1.03 million, so 2.96% of the outstanding shares have been sold short.
| Short Interest | 1.03M |
| Short Previous Month | 1.15M |
| Short % of Shares Out | 2.96% |
| Short % of Float | 2.99% |
| Short Ratio (days to cover) | 4.29 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.18 billion and -$127.80 million in losses. Loss per share was -$3.56.
| Revenue | 1.18B |
| Gross Profit | 466.00M |
| Operating Income | 267.80M |
| Pretax Income | -149.50M |
| Net Income | -127.80M |
| EBITDA | 360.60M |
| EBIT | 267.80M |
| Loss Per Share | -$3.56 |
Full Income StatementBalance Sheet
The company has $95.40 million in cash and $1.24 billion in debt, with a net cash position of -$1.15 billion or -$33.06 per share.
| Cash & Cash Equivalents | 95.40M |
| Total Debt | 1.24B |
| Net Cash | -1.15B |
| Net Cash Per Share | -$33.06 |
| Equity (Book Value) | 38.90M |
| Book Value Per Share | 1.12 |
| Working Capital | 172.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $303.80 million and capital expenditures -$58.00 million, giving a free cash flow of $245.80 million.
| Operating Cash Flow | 303.80M |
| Capital Expenditures | -58.00M |
| Depreciation & Amortization | 92.80M |
| Net Borrowing | -189.70M |
| Free Cash Flow | 245.80M |
| FCF Per Share | $7.07 |
Full Cash Flow StatementMargins
Gross margin is 39.57%, with operating and profit margins of 22.74% and -10.85%.
| Gross Margin | 39.57% |
| Operating Margin | 22.74% |
| Pretax Margin | -12.69% |
| Profit Margin | -10.85% |
| EBITDA Margin | 30.62% |
| EBIT Margin | 22.74% |
| FCF Margin | 20.87% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.13% |
| Shareholder Yield | 1.13% |
| Earnings Yield | -5.42% |
| FCF Yield | 10.42% |
Analyst Forecast
The average price target for Ingevity is $85.50, which is 26.07% higher than the current price. The consensus rating is "Buy".
| Price Target | $85.50 |
| Price Target Difference | 26.07% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 2.49 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.49 |
| Piotroski F-Score | 5 |
